Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Donninger

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Cancer Letters|April 30, 2017
The role of the NORE1A tumor suppressor in Oncogene-Induced SenescenceThibaut Barnoud, M Lee Schmidt, Howard Donninger, et al.
Molecular Biology International|May 2, 2012
RASSF1A and the Taxol Response in Ovarian CancerSusannah Kassler, Howard Donninger, Michael J Birrer, et al.
Journal of Virological Methods|March 26, 2004
Rhinovirus detection: comparison of real-time and conventional PCRHayat Dagher, Howard Donninger, Paul Hutchinson, et al.
Transgenic Research|September 9, 2024
NORE1A loss promotes MASLD/MASHHoward Donninger, Katherine Hobbing, Gavin E Arteel, et al.
Cancer Research|May 9, 2018
RASSF1A Deficiency Enhances RAS-Driven Lung TumorigenesisM Lee Schmidt, Katharine R Hobbing, Howard Donninger, et al.
Plos One|July 3, 2013
p21-activated kinase 3 (PAK3) is an AP-1 regulated gene contributing to actin organisation and migration of transformed fibroblastsNina Holderness Parker, Howard Donninger, Michael J Birrer, et al.
Cancers|December 22, 2020
The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung CancerDesmond R Harrell Stewart, M Lee Schmidt, Howard Donninger, et al.
Seminars in Cell & Developmental Biology|June 12, 2016
Ras signaling through RASSF proteinsHoward Donninger, M Lee Schmidt, Jessica Mezzanotte, et al.
Journal of Thoracic Disease|June 28, 2019
The role of RASSF proteins in modulating RAS driven lung tumors <i>in vivo</i>Desmond Harrell Stewart, Katherine Hobbing, M Lee Schmidt, et al.
Cancers|March 22, 2016
Proteomics Analysis Reveals Novel RASSF2 Interaction PartnersThibaut Barnoud, Daniel W Wilkey, Michael L Merchant, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Cancer Letters|April 30, 2017
The role of the NORE1A tumor suppressor in Oncogene-Induced SenescenceThibaut Barnoud, M Lee Schmidt, Howard Donninger, et al.
Molecular Biology International|May 2, 2012
RASSF1A and the Taxol Response in Ovarian CancerSusannah Kassler, Howard Donninger, Michael J Birrer, et al.
Journal of Virological Methods|March 26, 2004
Rhinovirus detection: comparison of real-time and conventional PCRHayat Dagher, Howard Donninger, Paul Hutchinson, et al.
Transgenic Research|September 9, 2024
NORE1A loss promotes MASLD/MASHHoward Donninger, Katherine Hobbing, Gavin E Arteel, et al.
Cancer Research|May 9, 2018
RASSF1A Deficiency Enhances RAS-Driven Lung TumorigenesisM Lee Schmidt, Katharine R Hobbing, Howard Donninger, et al.
Plos One|July 3, 2013
p21-activated kinase 3 (PAK3) is an AP-1 regulated gene contributing to actin organisation and migration of transformed fibroblastsNina Holderness Parker, Howard Donninger, Michael J Birrer, et al.
Cancers|December 22, 2020
The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung CancerDesmond R Harrell Stewart, M Lee Schmidt, Howard Donninger, et al.
Seminars in Cell & Developmental Biology|June 12, 2016
Ras signaling through RASSF proteinsHoward Donninger, M Lee Schmidt, Jessica Mezzanotte, et al.
Journal of Thoracic Disease|June 28, 2019
The role of RASSF proteins in modulating RAS driven lung tumors <i>in vivo</i>Desmond Harrell Stewart, Katherine Hobbing, M Lee Schmidt, et al.
Cancers|March 22, 2016
Proteomics Analysis Reveals Novel RASSF2 Interaction PartnersThibaut Barnoud, Daniel W Wilkey, Michael L Merchant, et al.
Pageof 5